HEADER TRANSFERASE 13-MAR-18 5ZHM TITLE CRYSTAL STRUCTURE OF TRMD FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH TITLE 2 ACTIVE-SITE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 5-350; COMPND 5 SYNONYM: TRNA [GM37] METHYLTRANSFERASE; COMPND 6 EC: 2.1.1.228; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 208963; SOURCE 4 STRAIN: UCBPP-PA14; SOURCE 5 GENE: TRMD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS TRNA METHYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR W.ZHONG,K.K.PASUNOOTI,S.BALAMKUNDU,Y.W.WONG,Q.NAH,C.F.LIU,J.LESCAR, AUTHOR 2 P.C.DEDON REVDAT 4 22-NOV-23 5ZHM 1 REMARK REVDAT 3 25-SEP-19 5ZHM 1 JRNL REVDAT 2 04-SEP-19 5ZHM 1 JRNL REVDAT 1 06-MAR-19 5ZHM 0 JRNL AUTH W.ZHONG,K.K.PASUNOOTI,S.BALAMKUNDU,Y.H.WONG,Q.NAH,V.GADI, JRNL AUTH 2 S.GNANAKALAI,Y.H.CHIONH,M.E.MCBEE,P.GOPAL,S.H.LIM,N.OLIVIER, JRNL AUTH 3 E.T.BUURMAN,T.DICK,C.F.LIU,J.LESCAR,P.C.DEDON JRNL TITL THIENOPYRIMIDINONE DERIVATIVES THAT INHIBIT BACTERIAL TRNA JRNL TITL 2 (GUANINE37-N1)-METHYLTRANSFERASE (TRMD) BY RESTRUCTURING THE JRNL TITL 3 ACTIVE SITE WITH A TYROSINE-FLIPPING MECHANISM. JRNL REF J.MED.CHEM. V. 62 7788 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31442049 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00582 REMARK 2 REMARK 2 RESOLUTION. 2.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 16202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 813 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.76 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2875 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2510 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2725 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3775 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.71270 REMARK 3 B22 (A**2) : -11.71270 REMARK 3 B33 (A**2) : 23.42550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.390 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.375 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.375 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.916 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3917 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5301 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1401 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 97 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 585 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3917 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 481 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4557 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.49 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ZHM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1300007083. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6-8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16240 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.760 REMARK 200 RESOLUTION RANGE LOW (A) : 49.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.91 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.99300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5WYQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, PH 8.6-8.8, 20%(V/V) REMARK 280 MPD, 20%(W/V) PEG 1000, AND 5%(W/V) PEG200; THE CRYSTAL WAS REMARK 280 SOAKED WITH 1MM INHIBITOR., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 98.18067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 49.09033 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 49.09033 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 98.18067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 VAL A -8 REMARK 465 ASP A -7 REMARK 465 LEU A -6 REMARK 465 GLY A -5 REMARK 465 THR A -4 REMARK 465 GLU A -3 REMARK 465 ASN A -2 REMARK 465 LEU A -1 REMARK 465 TYR A 0 REMARK 465 PHE A 1 REMARK 465 GLN A 2 REMARK 465 GLY A 166 REMARK 465 HIS A 167 REMARK 465 ALA A 168 REMARK 465 ASP A 169 REMARK 465 SER A 170 REMARK 465 ALA A 171 REMARK 465 GLU A 172 REMARK 465 GLU A 173 REMARK 465 ASP A 174 REMARK 465 MET B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 SER B -11 REMARK 465 SER B -10 REMARK 465 GLY B -9 REMARK 465 VAL B -8 REMARK 465 ASP B -7 REMARK 465 LEU B -6 REMARK 465 GLY B -5 REMARK 465 THR B -4 REMARK 465 GLU B -3 REMARK 465 ASN B -2 REMARK 465 LEU B -1 REMARK 465 TYR B 0 REMARK 465 PHE B 1 REMARK 465 GLY B 166 REMARK 465 HIS B 167 REMARK 465 ALA B 168 REMARK 465 ASP B 169 REMARK 465 SER B 170 REMARK 465 ALA B 171 REMARK 465 GLU B 172 REMARK 465 GLU B 173 REMARK 465 ASP B 174 REMARK 465 SER B 175 REMARK 465 PHE B 176 REMARK 465 THR B 177 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 45 13.48 -145.39 REMARK 500 ARG A 119 -152.05 -98.03 REMARK 500 GLU A 125 -38.61 -39.15 REMARK 500 PHE A 176 3.01 58.13 REMARK 500 ALA A 193 50.59 39.99 REMARK 500 TYR B 45 16.69 -143.95 REMARK 500 TYR B 120 -140.37 58.28 REMARK 500 ALA B 193 55.10 38.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9D3 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SAM B 301 DBREF 5ZHM A 5 250 UNP Q02RL6 TRMD_PSEAB 5 250 DBREF 5ZHM B 5 250 UNP Q02RL6 TRMD_PSEAB 5 250 SEQADV 5ZHM MET A -18 UNP Q02RL6 INITIATING METHIONINE SEQADV 5ZHM HIS A -17 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS A -16 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS A -15 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS A -14 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS A -13 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS A -12 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER A -11 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER A -10 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLY A -9 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM VAL A -8 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM ASP A -7 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM LEU A -6 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLY A -5 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM THR A -4 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLU A -3 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM ASN A -2 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM LEU A -1 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM TYR A 0 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM PHE A 1 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLN A 2 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER A 3 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM MET A 4 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM MET B -18 UNP Q02RL6 INITIATING METHIONINE SEQADV 5ZHM HIS B -17 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS B -16 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS B -15 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS B -14 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS B -13 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM HIS B -12 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER B -11 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER B -10 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLY B -9 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM VAL B -8 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM ASP B -7 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM LEU B -6 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLY B -5 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM THR B -4 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLU B -3 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM ASN B -2 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM LEU B -1 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM TYR B 0 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM PHE B 1 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM GLN B 2 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM SER B 3 UNP Q02RL6 EXPRESSION TAG SEQADV 5ZHM MET B 4 UNP Q02RL6 EXPRESSION TAG SEQRES 1 A 269 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 269 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU TRP VAL SEQRES 3 A 269 GLY VAL VAL SER ILE PHE PRO GLU MET PHE ARG ALA ILE SEQRES 4 A 269 SER ASP TYR GLY ILE THR SER ARG ALA VAL LYS GLN GLY SEQRES 5 A 269 LEU LEU THR LEU THR CYS TRP ASN PRO ARG VAL TYR THR SEQRES 6 A 269 GLU ASP ARG HIS GLN THR VAL ASP ASP ARG PRO PHE GLY SEQRES 7 A 269 GLY GLY PRO GLY MET VAL MET LYS ILE LYS PRO LEU GLU SEQRES 8 A 269 GLY ALA LEU ALA ASP ALA ARG GLN ALA ALA GLY GLY ARG SEQRES 9 A 269 LYS ALA LYS VAL ILE TYR LEU SER PRO GLN GLY ARG GLN SEQRES 10 A 269 LEU THR GLN ALA GLY VAL ARG GLU LEU ALA GLU GLU GLU SEQRES 11 A 269 ALA LEU ILE LEU ILE ALA GLY ARG TYR GLU GLY ILE ASP SEQRES 12 A 269 GLU ARG PHE ILE GLU GLU HIS VAL ASP GLU GLU TRP SER SEQRES 13 A 269 ILE GLY ASP TYR VAL LEU SER GLY GLY GLU LEU PRO ALA SEQRES 14 A 269 MET VAL LEU VAL ASP ALA VAL THR ARG LEU LEU PRO GLY SEQRES 15 A 269 ALA LEU GLY HIS ALA ASP SER ALA GLU GLU ASP SER PHE SEQRES 16 A 269 THR ASP GLY LEU LEU ASP CYS PRO HIS TYR THR ARG PRO SEQRES 17 A 269 GLU VAL TYR ALA ASP LYS ARG VAL PRO GLU VAL LEU LEU SEQRES 18 A 269 SER GLY ASN HIS GLU HIS ILE ARG ARG TRP ARG LEU GLN SEQRES 19 A 269 GLN ALA LEU GLY ARG THR TRP GLU ARG ARG ALA ASP LEU SEQRES 20 A 269 LEU ASP SER ARG SER LEU SER GLY GLU GLU GLN LYS LEU SEQRES 21 A 269 LEU ALA GLU TYR ILE ARG GLN ARG ASP SEQRES 1 B 269 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 269 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU TRP VAL SEQRES 3 B 269 GLY VAL VAL SER ILE PHE PRO GLU MET PHE ARG ALA ILE SEQRES 4 B 269 SER ASP TYR GLY ILE THR SER ARG ALA VAL LYS GLN GLY SEQRES 5 B 269 LEU LEU THR LEU THR CYS TRP ASN PRO ARG VAL TYR THR SEQRES 6 B 269 GLU ASP ARG HIS GLN THR VAL ASP ASP ARG PRO PHE GLY SEQRES 7 B 269 GLY GLY PRO GLY MET VAL MET LYS ILE LYS PRO LEU GLU SEQRES 8 B 269 GLY ALA LEU ALA ASP ALA ARG GLN ALA ALA GLY GLY ARG SEQRES 9 B 269 LYS ALA LYS VAL ILE TYR LEU SER PRO GLN GLY ARG GLN SEQRES 10 B 269 LEU THR GLN ALA GLY VAL ARG GLU LEU ALA GLU GLU GLU SEQRES 11 B 269 ALA LEU ILE LEU ILE ALA GLY ARG TYR GLU GLY ILE ASP SEQRES 12 B 269 GLU ARG PHE ILE GLU GLU HIS VAL ASP GLU GLU TRP SER SEQRES 13 B 269 ILE GLY ASP TYR VAL LEU SER GLY GLY GLU LEU PRO ALA SEQRES 14 B 269 MET VAL LEU VAL ASP ALA VAL THR ARG LEU LEU PRO GLY SEQRES 15 B 269 ALA LEU GLY HIS ALA ASP SER ALA GLU GLU ASP SER PHE SEQRES 16 B 269 THR ASP GLY LEU LEU ASP CYS PRO HIS TYR THR ARG PRO SEQRES 17 B 269 GLU VAL TYR ALA ASP LYS ARG VAL PRO GLU VAL LEU LEU SEQRES 18 B 269 SER GLY ASN HIS GLU HIS ILE ARG ARG TRP ARG LEU GLN SEQRES 19 B 269 GLN ALA LEU GLY ARG THR TRP GLU ARG ARG ALA ASP LEU SEQRES 20 B 269 LEU ASP SER ARG SER LEU SER GLY GLU GLU GLN LYS LEU SEQRES 21 B 269 LEU ALA GLU TYR ILE ARG GLN ARG ASP HET 9D3 A 301 26 HET SAM B 301 27 HETNAM 9D3 N-({4-[(DIETHYLAMINO)METHYL]PHENYL}METHYL)-4-OXO-3,4- HETNAM 2 9D3 DIHYDROTHIENO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE HETNAM SAM S-ADENOSYLMETHIONINE FORMUL 3 9D3 C19 H22 N4 O2 S FORMUL 4 SAM C15 H22 N6 O5 S FORMUL 5 HOH *123(H2 O) HELIX 1 AA1 PHE A 13 MET A 16 5 4 HELIX 2 AA2 PHE A 17 ASP A 22 1 6 HELIX 3 AA3 TYR A 23 GLN A 32 1 10 HELIX 4 AA4 ASN A 41 THR A 46 5 6 HELIX 5 AA5 LYS A 67 GLY A 83 1 17 HELIX 6 AA6 THR A 100 GLU A 109 1 10 HELIX 7 AA7 ASP A 124 VAL A 132 1 9 HELIX 8 AA8 GLY A 146 LEU A 161 1 16 HELIX 9 AA9 PRO A 198 GLY A 204 1 7 HELIX 10 AB1 ASN A 205 ARG A 225 1 21 HELIX 11 AB2 ALA A 226 ARG A 232 1 7 HELIX 12 AB3 SER A 235 ARG A 249 1 15 HELIX 13 AB4 PHE B 13 MET B 16 5 4 HELIX 14 AB5 PHE B 17 ASP B 22 1 6 HELIX 15 AB6 TYR B 23 GLN B 32 1 10 HELIX 16 AB7 ASN B 41 THR B 46 5 6 HELIX 17 AB8 LYS B 67 GLY B 83 1 17 HELIX 18 AB9 THR B 100 GLU B 109 1 10 HELIX 19 AC1 ASP B 124 VAL B 132 1 9 HELIX 20 AC2 GLY B 146 ARG B 159 1 14 HELIX 21 AC3 PRO B 198 SER B 203 1 6 HELIX 22 AC4 GLU B 207 ARG B 225 1 19 HELIX 23 AC5 ALA B 226 ARG B 232 1 7 HELIX 24 AC6 SER B 235 GLN B 248 1 14 SHEET 1 AA1 6 LEU A 35 TRP A 40 0 SHEET 2 AA1 6 LEU A 5 VAL A 10 1 N VAL A 7 O THR A 36 SHEET 3 AA1 6 ALA A 112 ALA A 117 1 O LEU A 115 N VAL A 10 SHEET 4 AA1 6 ALA A 87 LEU A 92 1 N ILE A 90 O ILE A 116 SHEET 5 AA1 6 GLU A 134 SER A 137 1 O GLU A 134 N TYR A 91 SHEET 6 AA1 6 ARG A 97 GLN A 98 1 N ARG A 97 O GLU A 135 SHEET 1 AA2 3 ASP A 54 ASP A 55 0 SHEET 2 AA2 3 VAL A 65 MET A 66 -1 O VAL A 65 N ASP A 55 SHEET 3 AA2 3 GLY A 122 ILE A 123 1 O GLY A 122 N MET A 66 SHEET 1 AA3 2 VAL A 191 TYR A 192 0 SHEET 2 AA3 2 LYS A 195 ARG A 196 -1 O LYS A 195 N TYR A 192 SHEET 1 AA4 6 LEU B 35 TRP B 40 0 SHEET 2 AA4 6 LEU B 5 VAL B 10 1 N VAL B 7 O THR B 36 SHEET 3 AA4 6 ALA B 112 ALA B 117 1 O ALA B 117 N VAL B 10 SHEET 4 AA4 6 ALA B 87 LEU B 92 1 N ILE B 90 O ILE B 116 SHEET 5 AA4 6 GLU B 134 SER B 137 1 O GLU B 134 N TYR B 91 SHEET 6 AA4 6 ARG B 97 GLN B 98 1 N ARG B 97 O GLU B 135 SHEET 1 AA5 2 ASP B 54 ASP B 55 0 SHEET 2 AA5 2 VAL B 65 MET B 66 -1 O VAL B 65 N ASP B 55 SHEET 1 AA6 2 VAL B 191 TYR B 192 0 SHEET 2 AA6 2 LYS B 195 ARG B 196 -1 O LYS B 195 N TYR B 192 CISPEP 1 ARG A 188 PRO A 189 0 7.45 CISPEP 2 ARG B 188 PRO B 189 0 3.25 SITE 1 AC1 17 LEU A 92 SER A 93 PRO A 94 ARG A 119 SITE 2 AC1 17 TYR A 120 GLY A 122 SER A 137 ILE A 138 SITE 3 AC1 17 GLY A 139 TYR A 141 LEU A 143 GLY A 145 SITE 4 AC1 17 GLY A 146 PRO A 149 HOH A 404 ASP B 182 SITE 5 AC1 17 HIS B 185 SITE 1 AC2 21 ARG A 159 SER A 175 ASP A 182 HIS A 185 SITE 2 AC2 21 TYR B 91 LEU B 92 SER B 93 PRO B 94 SITE 3 AC2 21 GLN B 95 GLY B 118 TYR B 120 GLU B 121 SITE 4 AC2 21 GLY B 122 SER B 137 ILE B 138 GLY B 139 SITE 5 AC2 21 TYR B 141 LEU B 143 GLY B 145 GLY B 146 SITE 6 AC2 21 PRO B 149 CRYST1 84.500 84.500 147.271 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011834 0.006833 0.000000 0.00000 SCALE2 0.000000 0.013665 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006790 0.00000